Meloxicam Kleva 7,5 Mg

Active Ingredient:: Meloxicam
Origin:: EU

Meloxicam Kleva 7,5 Mg (Meloxicam)

Meloxicam, the active ingredient in Meloxicam Kleva 7.5 Mg is a NSAID for oral use. It works by reducing hormones that cause pain, fever, and inflammation in the body. It treats osteoarthritis, rheumatoid arthritis and acute pain in adults. Meloxicam is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints).

Meloxicam is also used to relieve the pain, tenderness, swelling, and stiffness caused by juvenile rheumatoid arthritis (a type of arthritis that affects children) in children 2 years of age and older.

GNH India supplies Meloxicam Kleva 7.5 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kleva Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Meloxicam is a non‑steroidal anti‑inflammatory drug used to manage inflammatory joint conditions and acute pain.

Osteoarthritis: reduces joint pain and improves functional ability.
Rheumatoid arthritis: decreases inflammation and slows disease progression.
Acute pain: provides short‑term relief of moderate pain.

How It Works

Meloxicam selectively inhibits cyclo‑oxygenase‑2 (COX‑2) enzymes, which reduces the conversion of arachidonic acid to prostaglandins. Lower prostaglandin levels diminish inflammation, pain signaling, and fever, providing therapeutic relief in musculoskeletal disorders while sparing COX‑1 mediated gastric protection to a greater extent than non‑selective NSAIDs.

Side Effects

Adverse reactions may occur with meloxicam use.

Common Side Effects

Gastro‑intestinal discomfort or dyspepsia.
Headache.
Dizziness.
Mild skin rash.
Elevated blood pressure.
Peripheral edema.

Serious or Rare Side Effects

Gastro‑intestinal ulceration or bleeding.
Severe liver injury (hepatotoxicity).
Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Acute renal impairment.
Cardiovascular thrombotic events (myocardial infarction, stroke).
Anaphylactic or severe hypersensitivity reactions.

Precautions & Warnings

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

Renal function: assess baseline and monitor in patients with renal impairment.
Hepatic function: evaluate liver enzymes prior to initiation and during therapy.
Cardiovascular risk: use cautiously in patients with a history of heart disease or stroke.
Gastro‑intestinal safety: avoid in patients with active peptic ulcer disease or a history of serious GI bleeding.
Pregnancy and lactation: contraindicated unless benefits outweigh potential risks; consult obstetric guidance.
Store at room temperature below 25°C: keep in the original container, protect from moisture and light.

Avoid Interactions

Meloxicam may interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid)

Anticoagulants (e.g., warfarin): increased risk of bleeding.
Lithium: elevated lithium serum concentrations.
Methotrexate: enhanced toxicity, especially at high doses.
Cyclosporine: heightened nephrotoxic potential.

Moderate Interactions (Monitor Closely)

ACE inhibitors or ARBs: possible decline in renal function.
Diuretics: risk of electrolyte imbalance and reduced renal clearance.
SSRIs or SNRIs: additive bleeding risk, monitor for signs of hemorrhage.

Frequently Asked Questions

Meloxicam Kleva 7,5 Mg is prescribed to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and other acute musculoskeletal pain conditions. It helps improve joint function and reduces discomfort in adult patients.

Meloxicam works by selectively inhibiting the cyclo‑oxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels, meloxicam diminishes inflammatory responses and provides analgesia.

The appropriate dose of Meloxicam Kleva 7,5 Mg is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual health factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of meloxicam in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Meloxicam offers relatively selective COX‑2 inhibition, which may provide effective pain relief with a lower incidence of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, individual response varies, and risk‑benefit assessment should be individualized.

Meloxicam Kleva should be stored at room temperature below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat, and direct light to maintain product stability throughout its shelf life.

Meloxicam Kleva is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce occasional stomach upset. Patients should swallow the tablet whole and not crush or chew it.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, renal impairment, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions. Patients should seek immediate medical attention if they notice signs of these conditions.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or those who have had recent coronary artery bypass surgery. It is also contraindicated in patients with severe renal or hepatic impairment unless specifically directed by a physician.

Medically reviewed by

Dr. Shweta Ashok More

M.Pharm (Quality Assurance), Ph.D. (Medicinal Chemistry), GNH India Pharmaceuticals Limited · Reviewed 9 Sep 2026

Published by GNH India Pharmaceuticals Limited · Last updated 15 Oct 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.